News Briefing channel feed – Endpoints News

News Briefing channel feed

Ji Xing buys Biogen’s acute ischemic stroke drug; Exelixis/BioInvent partnership ends; ClinChoice's deal in SEA

Last year

Dermavant's PhIII eczema data; Oxford's Nipah vaccine; Inventiva's €25M lifeline

Last year

Aclaris' mixed PhIIb eczema data; Amgen licenses Xeris' tech; Bolden Tx secures funding

Last year

TG licenses Precision's cell therapy; Innovent's PhIII weight loss win; Atea's positive hep C data

Last year

Senti Bio cuts 37% of staff; Evotec pockets $25M milestone from BMS; Novartis buys SanReno

Last year

Boehringer’s deal spree; Praxis’ licensing pact with Shanghai biotech; Vico Therapeutics raises $60M

Last year

Rhythm licenses obesity drug for $100M; Galapagos teams up with BridGene; Insilico’s new deal

Last year

J&J’s new partnership with Elektrofi; Enyo raises €39M; Arrowhead's $450M offering

Last year

AstraZeneca's $40M deal with Allorion; Apollo raises $33M; Xoma's stock buyback

Last year

Theseus goes with Tang; Oncternal trial patient dies; LianBio sells drug rights to J&J

Last year

Clene’s FDA update; JCR ends ties with Takeda, partners with AstraZeneca; Gilead ups stake in Hookipa

Last year

Passage Bio scraps a therapy; XOMA’s new loan; Impel is for sale

Last year

Kronos stops work on leukemia drug; Aldeyra shares rally on eczema data; Atavistik Bio's $40M

Last year

First Wave to merge with ImmunogenX; Caliway raises $100M; New deals for Replay’s Syena

Last year

AC Immune's Alzheimer's drug heads to PhIIb; CytoDyn HIV drug on full hold; Syndax to raise $200M

Last year

Apellis expects EU to reject eye drug; Terray teams up with Bristol Myers; Vandria raises $20M

Last year

Sofinnova details European investment strategy; C4's new PhI data; Coya closes $26M placement

Last year

Almirall partners with etherna; Daiichi's RNA deal with Depixus; SQZ founder's startup emerges from stealth

Last year

Affimed narrows PhI/IIa focus; Bristol Myers pays Agenus $25M; Merck, Moderna start another PhIII cancer vaccine

Last year

Novartis preps Kisqali for FDA; Ventyx cuts 20% of workers; Keytruda plus Lenvima hits PhIII setback

Last year

LianBio rejects Concentra bid; Treadwell cuts workers; AstraZeneca inks CAR-T deal

Last year

Ten63’s deal with Boehringer; Coya sets up agreement with Dr. Reddy’s; ReNAgade’s layoffs

Last year

AbbVie’s new AI deal; Roche's PhIII win in breast cancer; SpringWorks to raise $275M

Last year

Ideaya partners with Gilead; Lilly extends offer for Point; Theseus lets go of CEO, CMO

Last year

First page Previous page 11 12 131415 16 17 Next page Last page